Note 6 – Stock Compensation

The Company uses the fair value method of accounting for share-based compensation arrangements. The fair value of stock options is estimated at the date of grant using the Black-Scholes option valuation model. Stock-based compensation expense is reduced for estimated forfeitures and is amortized over the vesting period using the straight-line method.

The following table summarizes the allocation of non-cash stock-based compensation to our expense categories for the three months ended March 31, 2020 and 2019 (in thousands):


	Three Months Ended
	March 31,
	2020		2019
Cost of revenues	$	6	$	8
Research and development		17		24
Selling, general and administrative		20		161
Total stock compensation expense	$	43	$	193

At March 31, 2020, total unrecognized compensation costs related to stock options was approximately $0.2 million, net of estimated forfeitures. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures and is expected to be recognized over a weighted average period of approximately 0.4 years.

The following key assumptions were used in the Black-Scholes option pricing model to determine the fair value of stock options granted:


	Three Months Ended
	March 31,
	2020			2019
Dividend yield		0	%	0	%
Risk free interest rates		2.48	%	2.48	%
Expected volatility		41.7 to 49.2	%	41.7 to 49.2	%
Expected term (in years)		3.5 to 4.8		3.5 to 4.8

The Company does not expect to pay dividends in the near future. Therefore, the Company used an expected dividend yield of 0%. The risk-free interest rate used in the Black-Scholes option pricing model is based on applicable yield available at the date of the option grant on U.S. Treasury securities with an equivalent term. Expected volatility is based on the weighted average historical volatility of the Company’s common stock for the equivalent term. The expected term of the options represents the period that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience and vesting schedules of similar awards.

A summary of the Company’s stock option activity for three months ended March 31, 2020 is presented in the following table (unaudited):



	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (In Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2019		5,404,985	$	2.40
Options granted		—		—
Options exercised		—		—
Options forfeited		—		—
Options cancelled or expired		(221,625)		3.46
Outstanding at March 31, 2020		5,183,360	$	2.40		3.27	$	—
Vested or expected to vest at March 31, 2020 (1)		5,180,131	$	2.40		3.27	$	—
Exercisable at March 31, 2020		5,021,954	$	2.40		3.27	$	—

(1)

The expected to vest options are the result of applying the pre-vesting forfeiture rate assumptions to total unvested options.

The aggregate intrinsic value in the table above represents the difference between the exercise price of the underlying options and the quoted price of the Company’s common stock. The aggregate intrinsic value of options exercised was zero for the three months ended March 31, 2020. The Company issues new shares of common stock upon exercise of stock options.